Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowEuropean Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating neuroscience and genomics findings into improved psychiatric treatments and public health impact.
Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
European Neuropsychopharmacology accepts the following article types. Click on an article type to view submission instructions.
Full Length Research Papers
Reviews On Specialised Topics
Short Communications
Letters To The Editor
Insights Papers
Recent Publications
Rethinking neurocognitive and cardiometabolic screening in severe mental illness
Michele De Prisco, Vincenzo Oliva
The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal study
G. Mezquida, A. Perez-Ramos, N. Guasch-Capella, M.F. Forte, M. Parellada, S. Amoretti, M. Serra-Navarro, J. Galvañ, M.J. Cuesta, A. Mané, E. De la Serna, M. Mitjans, M. Bioque, C. García-Rizo, A.G. Segura, Acronym PEPs Group
Antidepressant use and colorectal cancer risk: A systematic review and meta-analysis of epidemiological studies
Cuiling Wei, Oscar Mahasriariyawong, Peng Wu, Francisco Tsz Tsun Lai
Response to Ma et al.
Adam F. Kemp, Simon Anhøj, Anna Mejldal, Peter N. Schøler, Rikke Wesselhoeft, Maria M. Guala, Christoph U. Correll, Marco Solmi, Angelina I. Mellentin, Mikkel Højlund
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD✰
David W. Goodman, Rajnish Mago, Leslie Citrome, Holly A. Swartz, Roger S. McIntyre, Marlene P. Freeman, Anita H. Clayton, Siegfried Kasper, Eduard Vieta, Arthur Robin Williams, Mark A. Frye, Michael J. Gitlin, Lawrence J. Cohen, Christoph U. Correll, Philip Gorwood, Dan V. Iosifescu, Manish K. Jha, Ralph Kupka, Matthew Macaluso, Gin S. Malhi, Philip B. Mitchell, Snehal Bhatt, Mauricio Tohen, Andrew A. Nierenberg, Martha Sajatovic, Michael E. Thase, Joseph Zohar, Scott T. Aaronson, Joel L. Young, Joseph F. Goldberg
Frequently asked questions
How long does it take to publish?
45 days from submission to decision after review; 33 days from submission to acceptance.
Reformat to European Neuropsychopharmacology using Livewrite PremiumIs a cover letter required?
A covering letter must accompany all submissions.
Reformat to European Neuropsychopharmacology using Livewrite PremiumWhat are the publication costs?
USD 3000 excl. taxes for open access articles; no open access publication fee for subscription articles.
Reformat to European Neuropsychopharmacology using Livewrite Premium